Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5 or 6 infection: An integrated analysis of phase 2 and 3 studies Yao, B., Asselah, T., Fredrick, L., Schnell, G., Kowdley, K. V., Kwo, P., Poordad, F., Kinh Nguyen, Lee, S., Mensa, F. ELSEVIER SCIENCE BV. 2019: E248

View details for Web of Science ID 000463481701051